JP2023061920A - Ｃｄ環側鎖置換ビタミンｄ誘導体 - Google Patents

Ｃｄ環側鎖置換ビタミンｄ誘導体 Download PDF

Info

Publication number
JP2023061920A
JP2023061920A JP2022168144A JP2022168144A JP2023061920A JP 2023061920 A JP2023061920 A JP 2023061920A JP 2022168144 A JP2022168144 A JP 2022168144A JP 2022168144 A JP2022168144 A JP 2022168144A JP 2023061920 A JP2023061920 A JP 2023061920A
Authority
JP
Japan
Prior art keywords
mixture
mmol
added
etoac
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022168144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023061920A5 (enExample
Inventor
敦史 橘▲高▼
Atsushi Kittaka
文裕 川越
Fumihiro Kawagoe
利之 榊
Toshiyuki Sakaki
佳織 安田
Kaori Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teikyo University
Toyama Prefectural University
Original Assignee
Teikyo University
Toyama Prefectural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikyo University, Toyama Prefectural University filed Critical Teikyo University
Publication of JP2023061920A publication Critical patent/JP2023061920A/ja
Publication of JP2023061920A5 publication Critical patent/JP2023061920A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2022168144A 2021-10-20 2022-10-20 Ｃｄ環側鎖置換ビタミンｄ誘導体 Pending JP2023061920A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021171650 2021-10-20
JP2021171650 2021-10-20

Publications (2)

Publication Number Publication Date
JP2023061920A true JP2023061920A (ja) 2023-05-02
JP2023061920A5 JP2023061920A5 (enExample) 2025-10-09

Family

ID=86058300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022168144A Pending JP2023061920A (ja) 2021-10-20 2022-10-20 Ｃｄ環側鎖置換ビタミンｄ誘導体

Country Status (2)

Country Link
JP (1) JP2023061920A (enExample)
WO (1) WO2023068322A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025108575A1 (en) * 2023-11-21 2025-05-30 Roche Diagnostics Gmbh Methods of selective deprotection and synthesis of transhydrindane- skeleton-based compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004033420A1 (ja) * 2002-10-10 2006-02-09 ウイスコンシン アラムナイ リサーチ フオンデーシヨンＷｉｓｃｏｎｓｉｎ Ａｌｕｍｎｉ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ ２，２−ジ置換−１α，２５−ジヒドロキシ−１９−ノルビタミンＤ誘導体
WO2004067504A1 (ja) * 2003-01-31 2004-08-12 Chugai Seiyaku Kabushiki Kaisha ２位置換ビタミンｄ誘導体
WO2016191583A1 (en) * 2015-05-26 2016-12-01 Wisconsin Alumni Research Foundation 1α,25-DIHYDROXY-24,24-DIFLUORO-19-NOR-VITAMIN D3 ANALOGS AND THEIR PHARMACEUTICAL USES

Also Published As

Publication number Publication date
WO2023068322A1 (ja) 2023-04-27

Similar Documents

Publication Publication Date Title
KR0144358B1 (ko) 비타민 d 동족체
RU2509071C2 (ru) Новые липидные соединения
KR100321414B1 (ko) 비타민d아미드유도체
US7531527B2 (en) 2-Propylidene-19-nor-vitamin D compounds
AU707942B2 (en) New vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
KR100271461B1 (ko) 비타민 d 아미드 유도체
JPH04506965A (ja) 新規ビタミンｄ類似体
AU2004220477B2 (en) 2-Substituted vitamin D analogues and their therapeutic uses
TW200934502A (en) New vitamin D receptor activators and methods of making
US20120270934A1 (en) Prostacyclin derivatives
JP5552314B2 (ja) 新規脂質化合物
CA2653772C (en) 9,10-secopregnane derivative and pharmaceutical
JP2023061920A (ja) Ｃｄ環側鎖置換ビタミンｄ誘導体
US8106035B2 (en) 25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3
EP0664287B1 (en) Vitamin D compounds and method of preparing these compounds
EP2248798A1 (en) Novel lipid compounds
EP1091936B1 (en) Method for making hydroxy-25-ene-vitamin d compounds
JP2024155863A (ja) Ｃｄ環側鎖置換ビタミンｄ誘導体含有ｉｌ－１９分泌抑制剤
CA2589229C (en) 9,10-secopregnane derivatives and medicine
JP2005500402A (ja) １α，２５−ジヒドロキシビタミンＤ３の２４−硫黄置換類縁体
JP7773148B2 (ja) ビタミンｄ活性を有するリトコール酸誘導体
JP4361528B2 (ja) ビタミンｄ３ラクトン誘導体
US5354872A (en) Process for preparation of calcitriol lactone and related intermediates
AU2007306292A1 (en) Novel method of treatment of male sub-fertility
MXPA00011210A (en) Method for making hydroxy-25-ene-vitamin d compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20221021

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20221101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251001

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251001